← Back to Patent Explorer
US4814335A Expired / Lapsed US ⏱️ 0.0 years remaining

Antiviral compounds

Assignee: Ipsen Bioscience Inc
•
Filing: 1987-06-23
•
Granted: 1989-03-21
•
Expires: 2007-06-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract In one aspect, compounds having antiviral activity and having the general formula: ##STR1## wherein each R 2 , independently, is H or lower (fewer than 6 carbon atoms) alkyl; each R 3 , independently, is H or lower alkyl; R 0 is H or lower alkyl; R 1 is H or lower alkyl; 1≦n≦11; n-2≦m≦2n; 0≦p≦3; z is 0 or 1; and p≦1≦2p; each n, m, p, and q being selected so that the sp 3 valence shell of each carbon atom in each ring is filled; or a pharmaceutically acceptable salt thereof.

Inventors

  • 👤 Sun H. Kim

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 17:15
CPC Classifications
C; C07; C07D; C07D239/00; C07D239/70; C07D239/72; C07D239/95; A; A61; A61P; A61P31/00; A61P31/04; A61P31/12; A61P35/00; A61P37/00

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 82 words
A compound having the formula: ##STR6## wherein X is (CH 2 ) n where 1≦n≦3, or ##STR7## where R 4 is lower alkyl; and R 3 and R 5 , independently, are H, fluoro, nitro, amino, lower alkylamino, lower dialkylamino; arylamino (wherein aryl does not include aromatic heterocycle), acylamido, carboxy, azido, lower alkoxy, trimethylsulfonyl, trifluoromethanesulfonyl, or lower alkoxycarbonyl, provided that when X is (CH 2 ) 2 , R 3 cannot be H or lower alkoxy; or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim 82 words
A compound having the formula: ##STR6## wherein X is (CH 2 ) n where 1≦n≦3, or ##STR7## where R 4 is lower alkyl; and R 3 and R 5 , independently, are H, fluoro, nitro, amino, lower alkylamino, lower dialkylamino; arylamino (wherein aryl does not include aromatic heterocycle), acylamido, carboxy, azido, lower alkoxy, trimethylsulfonyl, trifluoromethanesulfonyl, or lower alkoxycarbonyl, provided that when X is (CH 2 ) 2 , R 3 cannot be H or lower alkoxy; or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim 53 words
A compound having the formula ##STR8## wherein X is (CH 2 ) n where 1≦n≦3, or ##STR9## where R 4 is lower alkyl; and R 3 is fluoro, nitro, amino, lower alkylamino; lower dialkylamino, arylamino (wherein aryl does not include aromatic heterocycle), acylamido, carboxy, or lower alkoxycarbonyl; or a pharmaceutically acceptable salt thereof.
Claim 4
Dependent Claim 53 words
A compound having the formula ##STR8## wherein X is (CH 2 ) n where 1≦n≦3, or ##STR9## where R 4 is lower alkyl; and R 3 is fluoro, nitro, amino, lower alkylamino; lower dialkylamino, arylamino (wherein aryl does not include aromatic heterocycle), acylamido, carboxy, or lower alkoxycarbonyl; or a pharmaceutically acceptable salt thereof.
Claim 5
Dependent Claim 29 words
The compound of claim 1, wherein X is (CH 2 ) 3 , R 3 is fluoro, and R 5 is H said compound having the formula 2-amino-10-fluoro-4-oxo-5,6,7-trihydrobenzocyclohepta (6,5-d)-pyrimidine.
Claim 6
Dependent Claim 29 words
The compound of claim 1, wherein X is (CH 2 ) 3 , R 3 is nitro, and R 5 is H said compound having the formula 2-amino-10-nitro-4-oxo-5,6,7-trihydrobenzocyclohepta (6,5-d)-pyrimidine.
Claim 7
Dependent Claim 29 words
The compound of claim 1, wherein X is (CH 2 ) 3 , R 3 is amino, and R 5 is H said compound having the formula 2,10-diamino-4-oxo-5,6,7-trihydrobenzocyclohepta (6,5-d)-pyrimidine.
Claim 8
Dependent Claim 29 words
The compound of claim 1, wherein X is (CH 2 ) 3 , R 3 is azido, and R 5 is H said compound having the formula 2-amino-10-azido-4-oxo-5,6,7-trihydrobenzocyclohepta (6,5-d)-pyrimidine.
Claim 9
Dependent Claim 24 words
A biological response modifying composition comprising an effective amount of the compound of claim 1, or 2, together with a pharmaceutically acceptable carrier substance.
Claim 10
Dependent Claim 30 words
The composition of claim 7 wherein said composition is in the form of a pill, capsule, or tablet for oral administration to a human patient in need of said compound.
Claim 11
Dependent Claim 35 words
The composition of claim 7 wherein said composition is in the form of an ointment, lotion, cream, powder, gel, or spray for application to the skin of a human patient in need of said compound.
Claim 12
Dependent Claim 17 words
An anti-herpes simplex type II compound as set forth in any one of claims 1, or 2.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-03-20 1992-09-19 1993-03-21 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-03-20 1996-09-19 1997-03-21 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-03-20 2000-09-19 2001-03-21 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag